Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Atara Biotherapeutics, Inc. for potential violations of securities laws
(NASDAQ:ATRA), PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a preeminent national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. (Nasdaq: ATRA) (“Atara” or the “Company”). The investigation […]